I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 34% ± 14% | |
| epithelial cell | 8 studies | 35% ± 20% | |
| fibroblast | 6 studies | 25% ± 7% | |
| natural killer cell | 6 studies | 18% ± 3% | |
| endothelial cell | 5 studies | 27% ± 11% | |
| pericyte | 5 studies | 19% ± 5% | |
| regulatory T cell | 5 studies | 17% ± 2% | |
| classical monocyte | 4 studies | 25% ± 8% | |
| kidney loop of Henle epithelial cell | 4 studies | 19% ± 5% | |
| connective tissue cell | 4 studies | 23% ± 4% | |
| myofibroblast cell | 4 studies | 17% ± 1% | |
| basal cell | 4 studies | 33% ± 17% | |
| CD8-positive, alpha-beta T cell | 4 studies | 17% ± 1% | |
| goblet cell | 4 studies | 25% ± 11% | |
| plasmacytoid dendritic cell | 4 studies | 26% ± 7% | |
| plasmablast | 3 studies | 47% ± 15% | |
| pancreatic A cell | 3 studies | 31% ± 10% | |
| hematopoietic precursor cell | 3 studies | 25% ± 4% | |
| non-classical monocyte | 3 studies | 28% ± 5% | |
| smooth muscle cell | 3 studies | 17% ± 2% | |
| type I pneumocyte | 3 studies | 23% ± 4% | |
| erythroblast | 3 studies | 30% ± 14% | |
| abnormal cell | 3 studies | 22% ± 5% | |
| macrophage | 3 studies | 22% ± 3% | |
| dendritic cell | 3 studies | 32% ± 7% | |
| enteroendocrine cell | 3 studies | 30% ± 18% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% |
